PI
CLB icon

Placemark Investments’s Core Laboratories CLB Stock Holding History

Placemark Investments’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		$9.62M Buy
79,967
+55,987
+233% +$7.35M 0.17% 141
2014
Q3 		$3.51M Buy
23,980
+2,514
+12% +$388K 0.06% 355
2014
Q2 		$3.59M Buy
21,466
+5,508
+35% +$980K 0.06% 362
2014
Q1 		$3.16M Sell
15,958
-6,440
-29% -$1.22M 0.06% 380
2013
Q4 		$4.27M Buy
22,398
+157
+0.7% +$29.2K 0.07% 330
2013
Q3 		$3.76M Buy
22,241
+1,331
+6% +$207K 0.07% 327
2013
Q2 		$3.17M Buy
+20,910
New +$2.96M 0.07% 348

Other funds holding CLB

ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
WP
Wedgewood Partners St Louis, Missouri $484M AUM 14.59% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Placemark Investments's CLB Position: Q4 2014 in Review

Placemark Investments increased its Core Laboratories (CLB) stake by 233% in Q4 2014, buying an estimated $7.35M and bringing the position to 79,967 shares worth $9.62M. The position accounts for 0.17% of the portfolio, ranked #141.

Placemark Investments first reported a position in CLB in Q2 2013 and has held it in 7 quarters since. 345 funds tracked by Wall St. Rank hold CLB as of Q4 2014.

  • Placemark Investments held 79,967 shares of Core Laboratories worth $9.62M as of Q4 2014.
  • Placemark Investments bought 55,987 Core Laboratories shares in Q4 2014, an estimated $7.35M.
  • Core Laboratories made up 0.17% of Placemark Investments's portfolio in Q4 2014, its #141 holding.
  • Placemark Investments first reported a position in Core Laboratories in Q2 2013 and has held it in 7 quarters since.
  • 345 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2014.

Based on Placemark Investments's 13F filing for Q4 2014, filed 17 Feb 2015.